Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

被引:14
作者
Ambrosini, Giulia [1 ]
Cordani, Marco [2 ,3 ]
Zarrabi, Ali [4 ,5 ]
Alcon-Rodriguez, Sergio [6 ,7 ,8 ]
Sainz, Rosa M. [6 ,7 ,8 ]
Velasco, Guillermo [2 ,3 ]
Gonzalez-Menendez, Pedro [6 ,7 ,8 ]
Dando, Ilaria [1 ]
机构
[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy
[2] Univ Complutense Madrid, Fac Biol, Dept Biochem & Mol Biol, Madrid 28040, Spain
[3] Inst Invest Sanit San Carlos IdISSC, Madrid 28040, Spain
[4] Istinye Univ, Fac Engn & Nat Sci, Dept Biomed Engn, TR-34396 Istanbul, Turkiye
[5] Saveetha Univ, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Dept Res Analyt, Chennai 600077, India
[6] Sch Med, Dept Morfol & Biol Celular, Julian Claveria 6, Oviedo 33006, Spain
[7] Univ Oviedo, Inst Univ Oncol Principado Asturias IUOPA, Oviedo 33006, Spain
[8] Hosp Univ Cent Asturias HUCA, Inst Invest Sanit Principado Asturias ISPA, Oviedo 33011, Spain
关键词
Prostate cancer; Oncometabolites; Epigenetic alterations; Cancer stem cells (CSCs); Metabolic Enzymes; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN SEMINAL FLUID; ANDROGEN RECEPTOR; TGF-BETA; STROMAL FIBROBLASTS; SUPPRESSOR-CELLS; REACTIVE STROMA; GENE-EXPRESSION; GROWTH; METABOLISM;
D O I
10.1186/s12964-023-01462-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostate cancer, as one of the most prevalent malignancies in males, exhibits an approximate 5-year survival rate of 95% in advanced stages. A myriad of molecular events and mutations, including the accumulation of oncometabolites, underpin the genesis and progression of this cancer type. Despite growing research demonstrating the pivotal role of oncometabolites in supporting various cancers, including prostate cancer, the root causes of their accumulation, especially in the absence of enzymatic mutations, remain elusive. Consequently, identifying a tangible therapeutic target poses a formidable challenge. In this review, we aim to delve deeper into the implications of oncometabolite accumulation in prostate cancer. We center our focus on the consequential epigenetic alterations and impacts on cancer stem cells, with the ultimate goal of outlining novel therapeutic strategies.
引用
收藏
页数:22
相关论文
共 209 条
[51]   The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression [J].
Espiritu, Shadrielle Melijah G. ;
Liu, Lydia Y. ;
Rubanova, Yulia ;
Bhandari, Vinayak ;
Holgersen, Erle M. ;
Szyca, Lesia M. ;
Fox, Natalie S. ;
Chua, Melvin L. K. ;
Yamaguchi, Takafumi N. ;
Heisler, Lawrence E. ;
Livingstone, Julie ;
Wintersinger, Jeff ;
Yousif, Fouad ;
Lalonde, Emilie ;
Rouette, Alexandre ;
Salcedo, Adriana ;
Houlahan, Kathleen E. ;
Li, Constance H. ;
Huang, Vincent ;
Fraser, Michael ;
Van der Kwast, Theodorus ;
Morris, Quaid D. ;
Bristow, Robert G. ;
Boutros, Paul C. .
CELL, 2018, 173 (04) :1003-+
[52]   Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite D-2-Hydroxyglutarate [J].
Fan, Jing ;
Teng, Xin ;
Liu, Ling ;
Mattaini, Katherine R. ;
Looper, Ryan E. ;
Vander Heiden, Matthew G. ;
Rabinowitz, Joshua D. .
ACS CHEMICAL BIOLOGY, 2015, 10 (02) :510-516
[53]   Lactate Metabolism in Human Lung Tumors [J].
Faubert, Brandon ;
Li, Kevin Y. ;
Cai, Ling ;
Hensley, Christopher T. ;
Kim, Jiyeon ;
Zacharias, Lauren G. ;
Yang, Chendong ;
Do, Quyen N. ;
Doucette, Sarah ;
Burguete, Daniel ;
Li, Hong ;
Huet, Giselle ;
Yuan, Qing ;
Wigal, Trevor ;
Butt, Yasmeen ;
Ni, Min ;
Torrealba, Jose ;
Oliver, Dwight ;
Lenkinski, Robert E. ;
Malloy, Craig R. ;
Wachsmann, Jason W. ;
Young, Jamey D. ;
Kernstine, Kemp ;
DeBerardinis, Ralph J. .
CELL, 2017, 171 (02) :358-+
[54]   Phenotypic plasticity and the epigenetics of human disease [J].
Feinberg, Andrew P. .
NATURE, 2007, 447 (7143) :433-440
[55]   Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay [J].
Fiaschi, Tania ;
Marini, Alberto ;
Giannoni, Elisa ;
Taddei, Maria Letizia ;
Gandellini, Paolo ;
De Donatis, Alina ;
Lanciotti, Michele ;
Serni, Sergio ;
Cirri, Paolo ;
Chiarugi, Paola .
CANCER RESEARCH, 2012, 72 (19) :5130-5140
[56]   Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality? [J].
Fidelito, Gio ;
Watt, Matthew J. ;
Taylor, Renea A. .
FRONTIERS IN ONCOLOGY, 2022, 11
[57]   Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade [J].
Flaig, Thomas W. ;
Salzmann-Sullivan, Maren ;
Su, Lih-Jen ;
Zhang, Zhiyong ;
Joshi, Molishree ;
Gijon, Miguel A. ;
Kim, Jihye ;
Arcaroli, John J. ;
Van Bokhoven, Adrie ;
Lucia, M. Scott ;
La Rosa, Francisco G. ;
Schlaepfer, Isabel R. .
ONCOTARGET, 2017, 8 (34) :56051-56065
[58]   Metabolic alterations and targeted therapies in prostate cancer [J].
Flavin, Richard ;
Zadra, Giorgia ;
Loda, Massimo .
JOURNAL OF PATHOLOGY, 2011, 223 (02) :283-294
[59]   Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis [J].
Franco, Omar E. ;
Jiang, Ming ;
Strand, Douglas W. ;
Peacock, James ;
Fernandez, Suzanne ;
Jackson, Roger S., II ;
Revelo, Monica P. ;
Bhowmick, Neil A. ;
Hayward, Simon W. .
CANCER RESEARCH, 2011, 71 (04) :1272-1281
[60]   Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites [J].
Franko, Andras ;
Shao, Yaping ;
Heni, Martin ;
Hennenlotter, Joerg ;
Hoene, Miriam ;
Hu, Chunxiu ;
Liu, Xinyu ;
Zhao, Xinjie ;
Wang, Qingqing ;
Birkenfeld, Andreas L. ;
Todenhoefer, Tilman ;
Stenzl, Arnulf ;
Peter, Andreas ;
Haering, Hans-Ulrich ;
Lehmann, Rainer ;
Xu, Guowang ;
Lutz, Stefan Z. .
CANCERS, 2020, 12 (07) :1-15